Semax: Cognitive Peptide, Nootropic Effects, and the Research Behind It
Medically reviewed by Medical Advisory Board Last reviewed 2026-07-27
How the Russian neuropeptide semax enhances BDNF, focus, and neuroprotection
Semax is a synthetic heptapeptide derived from ACTH (adrenocorticotropic hormone) that has been used in Russian medicine since the 1990s for stroke recovery, cognitive enhancement, and neuroprotection. It's one of the most researched cognitive peptides with both clinical and nootropic uses.
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic 7-amino-acid analog of a fragment of ACTH developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It received official approval in Russia for clinical use in the 1990s, primarily for treating cognitive impairment, stroke recovery, and optic nerve disorders.
Unlike ACTH itself, semax does not have hormonal activity on the adrenal glands — the modification preserves the neurological effects while eliminating the steroidogenic properties of the parent molecule. This specificity makes it valuable as a neuropeptide without systemic hormonal side effects.
Want expert help with your metabolic health?
We can match you with a metabolic-medicine specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →Semax is perhaps most notable for its BDNF (brain-derived neurotrophic factor) upregulation — it's one of the few compounds shown to significantly raise BDNF acutely, which supports neuroplasticity, long-term memory consolidation, and neuroprotection.
Semax Benefits and Mechanisms
- BDNF upregulation: Semax significantly increases BDNF expression in the hippocampus and cortex — effects seen within hours of administration. BDNF is crucial for neuroplasticity, memory, and protection against neurodegeneration.
- Dopaminergic and serotonergic modulation: Semax increases dopamine and serotonin turnover in the brain, which may contribute to its cognitive and mood effects.
- Neuroprotection: Reduces brain damage in ischemia models and is used clinically in Russia for stroke recovery.
- Focus and cognitive performance: Users commonly report improved focus, mental clarity, and working memory. Several controlled studies in Russia show cognitive enhancement effects.
- Anxiolytic effects (N-Acetyl Semax): The N-acetylated form shows more pronounced anxiolytic effects alongside cognitive enhancement.
- Optic nerve and vision: Used clinically in Russia for optic nerve atrophy and other visual system conditions.
Semax Regulatory Status in the US (2026)
Semax is not FDA-approved in the United States and has historically been available only as a research chemical — legal to purchase and possess, but not approved for human use. In Russia, where it was developed, semax is an approved prescription medication available at pharmacies.
In July 2026, the FDA Pharmacy Compounding Advisory Committee reviewed seven peptides that had been restricted from compounding access. Semax was among the six that received a favorable vote — the committee recommended it be made eligible for compounding by licensed US pharmacies. If the FDA accepts this recommendation, semax could become available through compounding pharmacies with a prescription, a significant improvement over the current research-chemical-only access. The FDA's final decision is pending; see our peptide regulation timeline for the latest.
Semax Forms and Dosage
Semax comes in several forms with different properties:
- Semax (standard): The base heptapeptide. Available as nasal spray (0.1% solution) or injectable. Nasal spray is most common for cognitive use.
- N-Acetyl Semax: Acetylated form with longer half-life and reported stronger anxiolytic component alongside cognitive effects.
- N-Acetyl Semax Amidate (NASSA): Most potent form; reportedly stronger BDNF upregulation.
Dosage (research reference):
- Intranasal: 200–900 mcg per day (1–3 sprays of 0.1% solution per nostril, depending on concentration)
- Injectable: 50–200 mcg subcutaneously per day
- Typical cycle: 2–4 weeks on, 1–2 weeks off
For a peptide from the same Russian research institute studied specifically for anxiety rather than cognition, see our semax vs selank comparison.
Frequently Asked Questions
What is semax?
Semax is a synthetic 7-amino-acid neuropeptide derived from ACTH, developed in Russia in the 1980s. It's been in clinical use there since the 1990s for cognitive impairment and stroke recovery. It works primarily through BDNF upregulation, dopaminergic/serotonergic modulation, and neuroprotection — without the hormonal activity of the parent ACTH molecule.
What does semax do?
Semax upregulates BDNF (brain-derived neurotrophic factor), enhancing neuroplasticity and memory. It modulates dopamine and serotonin activity, improving focus and cognitive performance. It provides neuroprotection in ischemia models and has been used clinically for stroke recovery. Users report improved focus, mental clarity, working memory, and sometimes mood stability.
Where to buy semax?
Semax is available as a research chemical from several online vendors (CosmicNootropic, Ceretropic-era suppliers, and others). It's not FDA-approved in the US but is legal to possess as a research compound. In Russia, it's available as a prescription nasal spray under the brand name Semax (0.1%). Quality verification is critical — buy from vendors who provide third-party testing.
Topic updates
Get the weekly peptide roundup
Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Reading
-
Semax vs Selank: Nootropic Peptides Compared for Focus, Mood, and Anxiety
Semax vs selank: cognitive-focus peptide vs anxiety-modulating peptide compared.